(c) 2024 PillSync.com

Isosorbide Mononitrate 20 MG Oral Tablet

INDICATIONS AND USAGE Isosorbide mononitrate tablets, USP are indicated for the prevention and treatment of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.

Actavis Elizabeth LLC

FDA Reported Adverse Reactions
[1] fatigue    [2] nausea    [3] drug ineffective    [4] pain    [5] off label use    [6] headache    [7] dyspnoea    [8] toxicity to various agents    [9] vomiting    [10] diarrhoea   

3 years ago ROUND BLUE R 620 Isosorbide Mononitrate 20 MG Oral Tablet

ROUND BLUE R 620

3 years ago ROUND BLUE R 620 Isosorbide Mononitrate 20 MG Oral Tablet

R 620 ROUND BLUE

HOW SUPPLIED

ISOSORBIDE MONONITRATE tablets, USP are available as follows: 10 mg — Each blue, round, tablet imprinted with and 631 on one side and scored on the other side, contains 10 mg of

ISOSORBIDE MONONITRATE (diluted), USP. Tablets are supplied in bottles of 100 (NDC 0228-2631-11). 20 mg — Each blue, round, tablet imprinted with and 620 on one side and scored on the other side, contains 20 mg of

ISOSORBIDE MONONITRATE (diluted), USP. Tablets are supplied in bottles of 100 (NDC 0228-2620-11). Dispense in tight containers as defined in the USP. Store at 25ºC (77ºF); excursions permitted to 15º to 30ºC (59º to 86ºF). Keep tightly closed. Manufactured In Bulgaria By: Balkanpharma - Dupnitsa AD Dupnitsa 2600, Bulgaria Manufactured For: Teva Pharmaceuticals Parsippany, NJ 07054 Rev. A 10/2022 596e94e8-figure-02 596e94e8-figure-03


More pills like ROUND R 620

Related Pills

Isosorbide Mononitrate 20 MG Oral Tablet

Actavis Pharma, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site